Company / Capital Returned to Shareholders
Revvity Capital Returned to Shareholders History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$853.6M
FY2025
5-year range
$105.4M / $853.6M
FY2021-FY2025
Trend
+111.3%
vs FY2024
Sector context
#23 of 108
Health Care
What the data says
Revvity's capital returned to shareholders of $854M is higher than 79% of companies in the Health Care sector (FY2025). Capital Returned to Shareholders has fluctuated over the past 10 years, ranging from $35M in FY2017 to $854M in FY2025.
Based on SEC 10-K filings.
$854M in FY2025 with a 5-year CAGR of +86.2%. Top quartile in the Health Care sector.
Improved from $424M to $854M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +94.5%
- 5-Year CAGR
- +86.2%
- 10-Year CAGR
- -
Sector benchmark
+13.1% above sector average
Key checks
Key Insights
- 5-year CAGR of +86.2%, indicating consistent growth.
- In FY2025, capital returned to shareholders increased 111.3% year-over-year.
- Ranks #23 out of 108 companies in the Health Care sector.
- Lowest capital returned to shareholders in the period was in FY2017.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $853.6M | +111.3% |
| FY2024 | $404.0M | -4.7% |
| FY2023 | $423.8M | +265.4% |
| FY2022 | $116.0M | +10.0% |
| FY2021 | $105.4M | +176.4% |
| FY2020 | $38.2M | +2.1% |
| FY2019 | $37.4M | -57.7% |
| FY2018 | $88.5M | +155.4% |
| FY2017 | $34.6M | -81.0% |
| FY2016 | $182.6M | +69.1% |
As of FY2025 · SEC 10-K · Updated Mar 14, 2026